The SCICONX Journal of Pharmaceutical Chemistry and Biopharmaceutics (JPCB) is committed to upholding the highest standards of scientific integrity, ethical publishing, and transparency. This editorial policy outlines the principles, responsibilities, and guidelines followed by authors, editors, reviewers, and the editorial office to ensure that the journal maintains its reputation as a trusted platform for high-quality research in pharmaceutical chemistry and biopharmaceutics.

1. Scope and Purpose

JPCB publishes original research, reviews, short communications, and case studies that contribute to advancing knowledge in:

• Pharmaceutical chemistry, drug design, and molecular modelling.
• Biopharmaceutics, drug delivery systems, and formulation science.
• Pharmacokinetics, pharmacodynamics, and clinical applications.
• Analytical methods, quality control, and regulatory sciences.
• Emerging trends in Nano-pharmaceutics, personalized medicine, and biopharmaceutical innovations.

The journal aims to provide a transparent, rigorous, and ethical platform for disseminating research that has scientific merit, practical relevance, and the potential to impact healthcare outcomes.

2. Editorial Responsibilities

Editors are responsible for:

1. Ensuring all submissions undergo fair, unbiased, and timely evaluation.
2. Maintaining confidentiality of manuscript content and author information.
3. Identifying potential conflicts of interest or ethical concerns in manuscripts.
4. Providing guidance to reviewers and ensuring constructive, evidence-based feedback.
5. Making final editorial decisions based on reviewer input, ethical compliance, and scientific merit.

3. Peer Review Policy

• JPCB follows a double-blind peer review process where both authors and reviewers remain anonymous.
• All submissions are evaluated by at least two independent reviewers with relevant expertise.
• Reviewers assess manuscripts for originality, methodology, accuracy, significance, and clarity.
• Editors monitor reviews to ensure fairness, objectivity, and constructive feedback.
• Authors are encouraged to address reviewer comments thoroughly during revisions.

4. Ethical Guidelines for Publication

JPCB adheres to international standards of publication ethics, including COPE and ICMJE guidelines:

1. Authorship and Contributions:
   • All listed authors must have made a substantial contribution to the research.
   • Guest, gift, or ghost authorship is strictly prohibited.
2. Plagiarism and Originality:
   • Manuscripts must be original and not under consideration elsewhere.
   • Plagiarism, including text, figures, or data duplication, is strictly prohibited.
3. Conflict of Interest:
   • Authors, editors, and reviewers must disclose any financial, personal, or professional conflicts.
   • Conflicts are managed to prevent bias in the review or editorial process.
4. Human and Animal Research:
   • Human studies must comply with the Declaration of Helsinki and receive institutional ethical approval.
   • Animal studies must follow institutional and national guidelines for care and use.
   • Informed consent must be obtained where applicable.
5. Data Integrity and Availability:
   • Authors must provide accurate, verifiable data.
   • Raw data may be requested to validate results or address queries.

5. Handling Misconduct

JPCB takes all allegations of research misconduct seriously. Potential issues include plagiarism, data fabrication or falsification, duplicate submission, or ethical breaches. Actions may include:

• Manuscript rejection during submission or post-publication.
• Notification to institutional authorities or funding agencies.
• Retraction or correction of published articles if necessary.

6. Corrections and Retractions

• Errata / Corrigenda: Minor errors that do not affect the study’s conclusions are corrected via an erratum.
• Retractions: Articles with significant errors, ethical violations, or unreliable results may be retracted, with notices explaining the reasons.
• Addenda / Updates: Additional information may be published post-publication to clarify or expand findings.

7. Open Access and Copyright Policy

• JPCB is a fully open-access journal, providing free and unrestricted access to all published content.
• Authors retain copyright of their work while granting JPCB the license to publish, distribute, and archive the article.

8. Transparency and Accountability

• All editorial and review decisions are based solely on scientific merit, originality, and ethical compliance.
• Editors, reviewers, and authors are held accountable for maintaining the integrity and credibility of the journal.
• JPCB publishes an annual report detailing editorial activity, including acceptance rates, review timelines, and ethical compliance metrics.

9. Contact for Editorial Policy Queries

For further clarification regarding editorial policies, ethical concerns, or publication standards, please contact:

Email: editor.jpcb@sciconxjournals.com

The journal is dedicated to advancing scientific knowledge with integrity, transparency, and excellence, ensuring that every published article contributes meaningfully to pharmaceutical chemistry and biopharmaceutics research.